KAYLEA BULTMANN: Open Payments
NPI 1811761760 · MARSHALL, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,679 in 92 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $801 · 2025 $1,679
Food & beverage: $1,679
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $499 |
| Novo Nordisk Inc | 18 | $223 |
| Amgen Inc. | 13 | $182 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $79 |
| Exact Sciences Corporation | 3 | $65 |
| PFIZER INC. | 4 | $65 |
| Verona Pharma, Inc. | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| Lilly USA, LLC | 3 | $49 |
| Ardelyx, Inc. | 2 | $49 |
Products named: FASENRA, BREZTRI, OTEZLA, JOURNAVX, Rybelsus, Ohtuvayre, Kerendia, Ozempic.
Industry payments across MO — which companies pay providers there.
